Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

BACKGROUND: Despite the effectiveness of the various targeted therapies currently approved for solid tumors, acquired resistance remains a persistent problem that limits the ultimate effectiveness of these treatments. Polyclonal resistance to targeted therapy has been described in multiple solid tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayle, Arnaud, Belcaid, Laila, Palmieri, Lola-Jade, Teysonneau, Diego, Cousin, Sophie, Spalato-Ceruso, Mariella, Aldea, Mihaela, Vasseur, Damien, Alame, Melissa, Blouin, Laura, Soubeyran, Isabelle, Nicotra, Claudio, Ngocamus, Maud, Hollebecque, Antoine, Loriot, Yohann, Besse, Benjamin, Lacroix, Ludovic, Rouleau, Etienne, Barlesi, Fabrice, Andre, Fabrice, Italiano, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625178/
https://www.ncbi.nlm.nih.gov/pubmed/37924050
http://dx.doi.org/10.1186/s12943-023-01878-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625178/
https://www.ncbi.nlm.nih.gov/pubmed/37924050
http://dx.doi.org/10.1186/s12943-023-01878-9

Ejemplares similares